Skip to main content

Table 2 Characteristics of the patients diagnosed with a non-AIDS-defining malignancy compared with the cohort.

From: Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study

  Cohort NADM No NADM Univariate Multivariate
  n % n % n % p value OR CI 95% p value OR CI 95%
Patients 3126 100 45 1.4 3081 98.6       
Included after 1 January 2002 1300 41.6 10 22.2 1290 41.9       
Median follow up 49 60 49       
Age > 45 at baseline 703 22.49 24 53.33 679 22.04 < 0.0001 4.04 2.24-7.31 < 0.0001 3.25 1.70-6.22
Smoking 984 31.5 19 42.2 965 31.3 0.1611      
MSM 875 28.0 11 24.4 864 28.0 0.714      
Male 1791 57.3 30 66.7 1761 57.2 0.2004      
African origin 1582 50.6 19 42.2 1563 50.7 0.3255      
HCV 319 10.2 10 22.2 309 10.0 0.0149 2.56 1.3 - 5.2 0.057 2.10 0.98-4.53
HBV 192 6.1 4 8.5 188 6.1 0.6453      
HIV diagnosis >5 years 1154 36.9 21 46.67 1133 36.77 0.1722      
Nadir CD4 count (cells/mm3) 220 110 224       
Nadir CD4 count < 200/mm3 before 1 January 2002 1410 45.10 35 77.78 1375 44.63 < 0.0001 4.34 2.14-8.80 0.005 3.10 1.40-6.87
CD4 count at baseline (cells/mm3) 402 375.5 405 0.2782      
VL at baseline 559 326 573 0.6767      
HAART use at baseline 78.0 71.4 78.1 0.7514      
Cumulative duration of HAART 39 50 38 0.1201      
Time since initiation of HAART 45 55 44 0.0279      
AIDS events before inclusion 635 20.31 15 33.3 620 20.12 0.0455 1.98 1.1 - 3.7 0.28 1.47 0.73-2.96
Death during study period 146 4.67 20 44.4 126 4.1 < 0.0001 18.76 10.1 - 34.7    
  1. Multivariate analysis was performed using logistic regression. Durations are in months. VL: viral load. OR: odds ratio